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Award-winning abstracts from the first Paediatric 
and Child Health Association of Malawi Conference
Theme: Using a multidisciplinary team approach to improve child health outcomes throughout Malawi
Neonatal acquisition of Group B 
Streptococcus in Malawi: a mother 
and infant cohort
Ethwako Mlia1,2, Todd Swarthout1, Yo Nishihara1, Queen 
Dube3, Mac Mallewa2
1. Malawi–Liverpool–Wellcome Trust Clinical Research Programme, 
College of  Medicine, University of  Malawi, Blantyre, Malawi
2. Department of  Paediatrics and Child Health, College of  Medicine, 
University of  Malawi, Blantyre, Malawi
3. Department of  Paediatrics, Queen Elizabeth Central Hospital, 
Blantyre, Malawi
Background
Group B Streptococcus (GBS) is a leading cause of  neonatal 
invasive disease and death in both developed and developing 
countries. Malawi has made significant progress towards 
Millennium Development Goal 4, with a considerable 
fall in under 5 mortality (currently 79/1000 live births). 
Unfortunately, neonatal mortality remains largely unchanged 
over the past decade (~17-22 deaths per 1000 live births 
annually in Malawi) with approximately one-third of  neonatal 
deaths in country being attributable to severe infection. 
Group B Streptococcus (GBS also known as Streptococcus 
agalactiae) is the most common cause of  neonatal sepsis 
and a target for control. In Malawi, GBS incidence in young 
infants is estimated to be 1.81/1000 live births (95% CI 
1.40–2.34) However, we need to better understand the true 
frequency of  infections, the biology of  disease in these 
settings, and, in particular, the relationship between maternal 
GBS carriage and neonatal invasive disease.
Objective
We hypothesized that contrary to established dogma, African 
neonatal GBS disease before and after the first week of  life is 
largely due to maternally-derived infection.
Methods: We conducted an unselected cohort study of  
pregnant women and their infants with active surveillance 
for neonatal sepsis and meningitis to ascertain those affected 
by GBS. We also conducted a nested sub-study to collect 
GBS strains from mother-infant pairs for the first month 
of  life, with weekly swabs of  the baby’s umbilicus, ears & 
throat.
Results
Maternal antenatal GBS colonization was 17%. Of  these 
GBS isolates, 20% were serotype Ia; 5% serotype Ib; 1% 
serotype II; 46% serotype III; 28% serotype V. This mother-
infant cohort had better than expected outcomes with lower 
than anticipated event rates, and lower than anticipated 
mortality rates. We had no episodes of  proven GBS sepsis/
meningitis within the cohort and fewer neonatal deaths than 
the national neonatal mortality rate of  17-22 deaths per 1000 
per year. Among the 293 mother/infant dyads recruited to 
the colonization substudy, 6% of  mothers were colonized 
with GBS (17% were serotype Ia; 61% serotype III; 22% 
serotype V). We suspect that this lower colonization rate may 
be due to the peripartum chlorhexidine vaginal cleansing now 
used widely in Malawi. 8.5% of  neonates were colonized at 
some time during the follow-up period (35% were serotype 
Ia; 42% serotype III; 19% serotype V; 4% serotype VIII).
Conclusions
Neonatal events were less common than expected. Maternal 
GBS colonization and serotype distribution is comparable to 
similar settings in the region. As expected there was mother-
to-infant GBS transmission, with evidence of  intrapartum 
transmission in 6 of  14 maternal carriers. However, in 9 non-
carrier mothers there was GBS acquisition demonstrated in 
all 9 babies, suggesting other common sources for early life 
acquisition. 
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The Paediatric and Child Health Association of  Malawi (PACHA) held its first conference from September 22 to 24 
2017 in Lilongwe, Malawi under the theme ‘Using a multidisciplinary team approach to improve child health outcomes 
throughout Malawi.’ Four guiding principles of  the conference research team were: (1) to link research with practice in low 
resource settings, (2) bring together members of  multiple disciplines to engender a more collaborative care environment 
for interprofessional pedagogy and practice, (3) facilitate communication between stakeholders at research institutions to 
identify shared goals in alignment with Malawi’s national health research agenda, and (4) set the foundation for an annual 
conference where findings will inform practice and policy in Malawi.  Out of  44 submissions, we selected four award-
winning abstracts in paediatric and child health to reflect excellence in discovery or implementation research in Malawi. 
The four winning abstracts are highlighted below. 
Elizabeth Glaser, Paul Pensulo, Pui-Ying Iroh Tam
(PACHA Research Committee)
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The Effect of hypothermia on 
survival for neonates admitted 
with acute respiratory Illness
Jennifer Carns1, Kondwani Kawaza2, Samantha Olvera1, Sara 
Liaghati-Mobarhan1, Samuel Ngwala3, Allysha Choudhury1, 
MK Quinn1, Aba Asibon1, Elizabeth Molyneux2, Maria 
Oden1, Rebecca Richards-Kortum1
1. Department of  Bioengineering/Rice 360 Institute for Global Health, 
Rice University, Houston, TX, USA 
2. Department of  Paediatrics and Child Health, College of  Medicine, 
University of  Malawi, Blantyre, Malawi
Background
Neonatal hypothermia is a global challenge and is widely 
associated with increased risks of  morbidity and mortality. 
Preterm infants are at an increased risk of  hypothermia as 
they have a high body surface area to weight ratio, but even 
the full term newborn often cannot produce sufficient heat 
to prevent a fall in body temperature, especially on the first 
day of  life.
Objective
To quantify case fatality rates for neonates admitted to central 
and district hospitals in Malawi for respiratory distress and 
treated with nasal oxygen and determine the impact of  
admission temperature and admission weight on survival.
Methods
The data for this analysis were collected at all 28 government 
district and central hospitals in Malawi. De-identified patient 
information was collected from standard Ministry of  Health 
Acute Respiratory Illness (ARI) forms for hospitalized 
neonates presenting with respiratory illness. Admission 
temperature, admission weight, and month of  admission 
were analyzed to determine incidence rates of  hypothermia 
(admission temperature <36.5°C) and the effect on survival 
for neonates treated with nasal O2. Differences in mean 
admission temperature were compared using a two-sided 
Student’s t-test, and relative risk was calculated with respect 
to normothermic neonates and stratified by admission 
temperature, admission weight, and month/season.
Results
Incidence rates of  hypothermia increased through the cold 
and rainy seasons (November-August) and decreased during 
the hot season (September-October).  Although incidence 
rates of  hypothermia were higher for infants with lower 
admission weights, there was no trend seen to correlate 
admission weight with season.  When stratified by weight, the 
average admission temperature for neonates who survived to 
discharge was higher than those who did not, and became 
statistically significant (p<0.05) amongst neonates with 
higher admission weights.  When stratified by month, the 
average admission temperature of  neonates who survived to 
discharge was always significantly higher than those who did 
not. Relative risk analyses showed that neonates with extreme 
hypothermia (<32°C) had a risk of  mortality nearly 4 times 
higher than those that were normothermic (36.5°C-37.5°C). 
Furthermore, extremely low admission weight neonates who 
were also extremely hypothermic (<1000g, <32°C) had a 
risk of  mortality nearly 7 times higher than those who were 
normothermic with an admission weight >2500g.   
Conclusion
Hypothermia upon admission is a pervasive problem 
affecting neonates in respiratory distress.
Strengthening practices that 
reduce hypothermia at birth: A 
case at Queen Elizabeth Central 
Hospital (QECH), Blantyre, 
Malawi
Edith Tewesa1, Esnath Kapito2, Ellen Chirwa2
1. Queen Elizabeth Central Hospital, Blantyre, Malawi
2. Kamuzu College of  Nursing, University of  Malawi, Blantyre, Malawi
Background
Hypothermia at birth contributes to neonatal morbidity and 
mortality in developing countries yet is a neglected aspect 
of  care. At Queen Elizabeth Central Hospital (QECH), the 
largest health facility in Malawi, 47 % of  neonates admitted 
during the first two months of  2016 had temperatures below 
36°C, meeting criteria for hypothermia. Factors contributing 
to low neonatal temperature included: inadequate drying 
at birth, inappropriate warming practices, lack of  adequate 
clothing and linens available at birth facilities, and a dearth 
of  training for staff  and mothers on the risks of  and ways to 
prevent hypothermia.
Objective
To reduce cases of  hypothermia in neonates born at QECH 
via a practice improvement initiative in the labour ward 
focusing on thermal protection at birth. 
Methods: We conducted trainings of  nurse midwives and 
support staff  to reinforce thermal protection practices at 
birth, which included immediate drying, use of  receiving 
towels, hats, bed sheets, and skin-to-skin contact for 1 hour 
after delivery. Information was disseminated through posters 
developed to share best practices on reducing hypothermia 
and through incorporating hypothermia prevention into 
antenatal lessons. 
Results and discussion
At baseline, the first two months of  2016, 47% of  neonates 
admitted to the unit met the criteria for hypothermia, i.e. 
temperatures below 36oC. Following training and resource 
mobilization, cases of  hypothermia decreased to 27.9% 
of  admitted neonates in December 2016, 26% in January 
2017, and 18.9 % in February 2017. This was a decline of  
59% over a 12 month period. Only 5.9% of  infants born at 
QECH between December 2016 and February 2017 were 
admitted to the neonatal unit with temperatures between 32-
34.9oC (moderate to extreme hypothermia), as compared to 
30% of  those referred from other facilities. 
Conclusions
Through training and resources mobilization, improved 
practices at birth were observed, including thorough drying, 
routine practices of  skin-to-skin contact for stable neonates, 
and availability and use of  receiving towels, hats, and posters 
in the labour ward. 
Leadership skills and mentorship are vital if  quality care is to 
be achieved. There is a need to roll out the project to referring 
health centres to determine if  the practices strengthened in 
this project will assist in improving the overall survival rates 
of  neonates.
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Treating brain swelling in 
paediatric cerebral malaria
Alice Wangui Liomba1,2
1. Blantyre Malaria Project, College of  Medicine, University of  Malawi, 
Blantyre, Malawi
2. Queen Elizabeth Central Hospital, Blantyre, Malawi
Background
Malaria remains a major cause of  morbidity and mortality 
claiming more than 750,000 lives each year.  Cerebral malaria 
(CM) is a severe complication characterized by coma and 
seizures with Plasmodium falciparum as the specific primary 
cause of  severe disease worldwide. The case fatality rate 
of  CM is 15-50% with an annual incidence ranging from 
1-12 cases per 1,000 children in malaria-endemic regions 
and 85% of  the morbidity and mortality occurring in young 
African children. Ongoing malaria studies in Malawi suggest 
that children with retinopathy-positive CM and increased 
brain volume have an increased likelihood of  mortality, 
with death occurring due to respiratory arrest secondary to 
intracranial hypertension. Although children with increased 
brain volume due to CM are at increased risk of  death, the 
majority recover quickly and completely, suggesting that the 
adverse effects of  the condition on respiratory status are 
reversible and short-lived hence this clinical trial. 
Objectives
(Primary) 1. Evaluate adjunct therapy targeting CM children 
with increased brain volume. 2. Compare final outcomes in 
pediatric CM patients receiving usual care (raising the head 
of  the bed at 30 degrees and anti- malarial treatment) with 
both of  the two interventions (usual care + immediate 
ventilation or usual care + hypertonic saline). (Secondary) 
Compare rates of  adverse neurological outcomes in those 
assigned to two interventions and those assigned to usual 
care among survivors. 
Methods
Study Design: This is a prospective, randomized, controlled 
non-blinded clinical trial of  two adjunctive therapeutic 
approaches in treating increased brain volume. Study 
Population: Malawian children, aged 6 months to 8 years, 
with cerebral malaria, known malarial retinopathy status and 
Magnetic Resonance Imaging (MRI) evidence of  severely 
increased brain volume. Total of  195 children, 65 randomised 
to each arm. Study Duration: Six years participant accrual; 
one year data analysis. Study Site: Paediatric Research Ward 
and Paediatric Intensive Care Unit, Queen Elizabeth Central 
Hospital, Blantyre Malawi. Collection Method: Data will be 
collected by study clinicians using standardised neurologic 
observations: The Malawi Developmental Assessment Tool 
(MDAT) for participants up to the age of  35 months, the 
Kaufman Assessment Battery for Children, Version II 
(KABC-II), for participants > 35 months, and Glasgow 
Outcome Scale (GOS). Analysis: ANOVA, nonparametric, 
and chi-square tests. 
Expected outcomes
Primary outcome: Treatment success or failure (a composite 
of  death, ventilatory rescue, and brain death) determined 
within 7 days of  entry. Secondary outcome: Neurological 
sequelae in survivors assessed on follow-up using MDAT, 
KABC II and GOS.
